Phase-out of CFCs in epinephrine inhalers
This article was originally published in The Gray Sheet
Executive Summary
FDA proposes elimination of "essential use" designation that continues to allow use of polluting chlorofluorocarbons in metered dose inhalers for epinephrine - available over-the-counter for mild asthma. The agency "has tentatively concluded that there are no substantial technical barriers to formulating epinephrine as a product that does not release CFCs," FDA explains in a Sept. 20 announcement. Inhalers with CFCs would be phased out by the end of 2010 under the proposed rule, on which FDA will seek public comment